Pharmala Biotech Holdings Inc. Stock Forecast
Explanation to Bollinger's Bands
Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.
Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.
Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation
BandWidth defines the current width of the band.
%b defines the current position within the band.
BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)
Live Samples:
Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.
Source: http://www.bollingerbands.com
High volatility in Pharmala Biotech Holdings Inc. stock price on Wednesday which ended trading at $0.125
(Updated on Jun 05, 2024)
The Pharmala Biotech Holdings Inc. stock price fell by -34.21% on the last day (Wednesday, 5th Jun 2024) from $0.190 to $0.125. During the last trading day the stock fluctuated 20.00% from a day low at $0.125 to a day high of $0.150. The price has fallen in 5 of the last 10 days and is down by -34.21% for this period. Volume has increased on the last day by 3 million shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 3 million shares were bought and sold for approximately $391.25 thousand.
Given the current short-term trend, the stock is expected to rise 8.41% during the next 3 months and, with a 90% probability hold a price between $0.136 and $0.259 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
MDMA.CN Signals & Forecast
Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Pharmala Biotech Holdings Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.181 and $0.196. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Wednesday, April 24, 2024, and so far it has fallen -45.65%. Further fall is indicated until a new bottom pivot has been found. Pharmala Biotech Holdings Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".
Support, Risk & Stop-loss for Pharmala Biotech Holdings Inc. stock
There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0250 between high and low, or 20.00%. For the last week, the stock has had daily average volatility of 7.21%.
Pharmala Biotech Holdings Inc. is oversold on RSI14 (22). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (MDMA.CN) For The Upcoming Trading Day Of Thursday 6th
For the upcoming trading day on Thursday, 6th we expect Pharmala Biotech Holdings Inc. to open at $0.133, and during the day (based on 14 day Average True Range), to move between $0.109 and $0.141, which gives a possible trading interval of +/-$0.0159 (+/-12.68%) up or down from last closing price. If Pharmala Biotech Holdings Inc. takes out the full calculated possible swing range there will be an estimated 25.36% move between the lowest and the highest trading price during the day.
With no support below and resistance from accumulated volume @ $0.155, some $0.0300 (24.00%) from the current price of $0.125, our system finds the risk reward not very attractive.
Is Pharmala Biotech Holdings Inc. stock A Buy?
The Pharmala Biotech Holdings Inc. stock holds several negative signals and despite the positive trend, we believe Pharmala Biotech Holdings Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.
Current score: -2.670 Sell Candidate Upgraded
Predicted Opening Price for Pharmala Biotech Holdings Inc. of Thursday, June 6, 2024
| Fair opening price June 6, 2024 | Current price |
|---|---|
| $0.133 ( 6.67%) | $0.125 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for MDMA.CN
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0.158 | 26.67% |
| R2 | 0.149 | 19.03% |
| R1 | 0.143 | 14.31% |
| Price | 0.125 | |
| S1 | 0.124 | -0.97% |
| S2 | 0.118 | -5.69% |
| S3 | 0.108 | -13.33% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0 | - |
| R2 | 0 | - |
| R1 | 0.155 | 24.00% |
| Price | 0.125 | |
| S1 | 0 | - |
| S2 | 0 | - |
| S3 | 0 | - |
FAQ
Click here for our free guide on how to buy Pharmala Biotech Holdings Inc. Stock.
